 The purpose of this clinical study is to undertake a pilot safety and efficacy study of a synthetic biodegradable membrane as a substitute for using donor human amniotic membrane hAM for the treatment of limbal stem cell deficiency LSCD by combining this with freshly excised limbal tissue in theatre as a one stage procedure 